股本结构
单位：万股
| 公告日期 | 2025-11-05 | 2025-07-30 | 2025-05-07 | 2025-02-05 | 2024-11-06 | 2024-07-31 |
|---|---|---|---|---|---|---|
| 证券总股本 | 114728.25 | 114715.09 | 114695.99 | 113383.87 | 113305.02 | 113290.89 |
| 普通股本 | 114728.25 | 114715.09 | 114695.99 | 113383.87 | 113305.02 | 113290.89 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
，当前存托凭证比例为：1
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-05 | 114728.25 | 未披露 | 定期报告 | 2025-09-30 |
| 2025-07-30 | 114715.09 | 未披露 | 定期报告 | 2025-06-30 |
| 2025-05-07 | 114695.99 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Issuance of Shares
|
2025-03-31 |
| 2025-02-05 | 113383.87 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Issuance of Shares
|
2024-12-31 |
| 2024-11-06 | 113305.02 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of Shares
|
2024-09-30 |
| 2024-07-31 | 113290.89 | 未披露 | 定期报告 | 2024-06-30 |
| 2024-05-08 | 113264.06 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of Shares
|
2024-03-31 |
| 2024-02-12 | 112109.40 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of Shares
|
2023-12-31 |
| 2023-11-09 | 112097.12 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-08-02 | 112065.01 | 未披露 |
更多>>
from March 31, 2023 to June 30, 2023
Issuance of Shares
|
2023-06-30 |
| 2023-05-10 | 112040.58 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of Shares
|
2023-03-31 |
| 2023-02-10 | 111089.98 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of Shares
|
2022-12-31 |
| 2022-11-03 | 111064.48 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-07-27 | 111056.47 | 未披露 |
更多>>
From December 31, 2021 to June 30, 2022
Issuance of Shares
|
2022-06-30 |
| 2022-04-13 | 111035.24 | 未披露 | 定期报告 | 2022-03-08 |
| 2022-02-09 | 110332.97 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of Shares
|
2021-12-31 |
| 2021-10-27 | 110300.72 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of Shares
|
2021-09-30 |
| 2021-07-28 | 110288.57 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of Shares
|
2021-06-30 |
| 2021-04-28 | 110234.91 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of Shares
|
2021-03-31 |
| 2021-02-10 | 109651.19 | 未披露 |
更多>>
From December 31,2019 to December 31,2020
Issuance of Shares
|
2020-12-31 |
| 2020-11-05 | 109597.16 | 未披露 | 定期报告 | 2020-09-30 |
| 2020-08-05 | 109577.68 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of Shares
|
2020-06-30 |
| 2020-05-07 | 109552.48 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of Shares
|
2020-03-31 |
| 2020-04-22 | 109531.62 | 未披露 | 定期报告 | 2020-03-10 |
| 2020-02-21 | 109218.90 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of Treasury Shares
Issuance of Shares
|
2019-12-31 |
| 2019-11-07 | 109208.94 | 未披露 | 定期报告 | 2019-09-30 |
| 2019-08-07 | 109190.63 | 未披露 |
更多>>
From March 31, 2019 to June 30, 2019
Issuance of Treasury Shares
|
2019-06-30 |
| 2019-05-02 | 109159.80 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of shares
|
2019-03-31 |
| 2019-02-19 | 108938.87 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of shares
Issuance of Treasury Shares
|
2018-12-31 |
| 2018-11-01 | 101871.14 | 未披露 | 定期报告 | 2018-10-30 |
| 2018-11-01 | 101900.00 | 370.00 | 定期报告 | 2018-09-30 |
| 2018-08-02 | 101828.25 | 未披露 | 定期报告 | 2018-07-30 |
| 2018-08-02 | 101800.00 | 370.00 | 定期报告 | 2018-06-30 |
| 2018-05-03 | 101822.68 | 未披露 | 定期报告 | 2018-04-30 |
| 2018-04-25 | 101822.00 | 未披露 | 定期报告 | 2018-04-12 |
| 2018-05-03 | 101800.00 | 370.00 | 定期报告 | 2018-03-31 |
| 2018-02-12 | 101687.71 | 370.00 |
更多>>
from December 31, 2016 to December 31, 2017
Exercise of options by employees and vested RSUs
|
2017-12-31 |
| 2017-08-03 | 101600.00 | 370.00 | 定期报告 | 2017-06-30 |
| 2017-02-15 | 101499.03 | 371.25 |
更多>>
from December 31, 2015 to December 31, 2016
Ordinary shares issuance
Exercise of options by employees and vested RSUs
|
2016-12-31 |
| 2016-11-15 | 101500.00 | 370.00 | 定期报告 | 2016-09-30 |
| 2016-05-09 | 91400.00 | 370.00 | 定期报告 | 2016-03-31 |
| 2016-02-11 | 90766.30 | 337.50 |
更多>>
from December 31, 2014 to December 31, 2015
Ordinary shares issuance
Exercise of options by employees and vested RSUs
Purchase of treasury shares
|
2015-12-31 |
| 2015-10-29 | 85200.00 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-07-30 | 85000.00 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-04-30 | 84800.00 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-02-09 | 85187.19 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Exercise of options and RSUs by employees
Purchase of treasury shares
|
2014-12-31 |
| 2014-10-30 | 85500.00 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-07-31 | 85400.00 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-02 | 85100.00 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-02-10 | 84786.81 | 未披露 |
更多>>
from December 31,2012 to December 31,2013
Exercise of options and RSUs by employees
Purchase of treasury shares
|
2013-12-31 |
| 2013-08-01 | 84500.00 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-05-02 | 85200.00 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-02-12 | 85700.00 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Exercise of options and RSUs by employees
Treasury shares
|
2012-12-31 |
| 2012-08-02 | 86800.00 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-09 | 87100.00 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-02-17 | 88300.00 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Exercise of options and RSUs by employees
Conversion of convertible senior debentures
Treasury shares
|
2011-12-31 |
| 2011-05-11 | 89200.00 | 未披露 | 定期报告 | 2011-03-31 |
| 2011-02-15 | 89700.00 | 未披露 |
更多>>
from December 31, 2009 to December 31, 2010
Exercise of options and RSUs by employees
Conversion of convertible senior debentures
|
2010-12-31 |
| 2010-11-02 | 89800.00 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-07-27 | 89700.00 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-05-04 | 89300.00 | 未披露 | 定期报告 | 2010-03-31 |
| 2010-02-22 | 88500.00 | 未披露 |
更多>>
from December 31, 2008 to December 31, 2009
Conversion of convertible senior debentures
Exercise of options by employees
Stock-based compensation expense
Excess tax benefit on options exercised
|
2009-12-31 |
| 2009-02-27 | 85100.00 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Issuance of shares and stock options on acquisitions
Conversion of convertible senior debentures
Exercise of options by employees
Stock-based compensation expense
Excess tax benefit on options exercised
Decrease
|
2008-12-31 |
| 2008-02-29 | 76800.00 | 未披露 |
更多>>
from December 31, 2006 to December 31, 2007
Conversion of convertible senior debentures
Exercise of options by employees
Stock-based compensation expense
Excess tax benefit on options exercised
Increase
|
2007-12-31 |
| 2007-02-28 | 75800.00 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Issuance of shares and stock option on acquisition of Ivax
Ordinary shares issued in exchange for special shares
Exercise of options by employees
Conversion of convertible senior debentures, net of tax
Treasury shares
|
2006-12-31 |
| 2006-03-20 | 61860.00 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Ordinary shares issued in exchange for special shares
Exercise of options by employees
Conversion of Convertible Senior Debentures and related tax effect
Cost of acquisition of Company shares, net of proceeds from sale
|
2005-12-31 |
| 2005-03-17 | 61140.00 | 未披露 |
更多>>
from December 31, 2003 to December 31, 2004
Issuance of shares, stock options and warrants on acquisition of Sicor
Ordinary shares issued in exchange for special shares
Exercise of options by employees
Conversion of Convertible Senior Debentures
Cost of acquisition of Company shares, net of proceeds from sale
In June 2004, Teva effected a 2:1 stock split
|
2004-12-31 |
| 2004-03-15 | 27340.00 | 未披露 |
更多>>
from December 31, 2002 to December 31, 2003
Exercise of options by employees and related tax effect
Conversion of Convertible Senior Debentures and related tax effect
Cost of acquisition of Company shares, net of proceeds from sale
|
2003-12-31 |
| 2003-03-04 | 25864.83 | 未披露 |
更多>>
from December 31, 2001 to December 31, 2002
Exercise of options by employees
Ordinary shares issued in exchange for special shares
Cost of acquisition of Company shares, net of proceeds from sale
At the end of 2002, Teva announced a 2:1 stock split
|
2002-12-31 |
From December 31, 2024 to March 31, 2025
Issuance of Shares
From December 31, 2023 to December 31, 2024
Issuance of Shares
From June 30, 2024 to September 30, 2024
Issuance of Shares
From December 31, 2023 to March 31, 2024
Issuance of Shares
From December 31, 2022 to December 31, 2023
Issuance of Shares
from March 31, 2023 to June 30, 2023
Issuance of Shares
From December 31, 2022 to March 31, 2023
Issuance of Shares
From December 31, 2021 to December 31, 2022
Issuance of Shares
From December 31, 2021 to June 30, 2022
Issuance of Shares
From December 31, 2020 to December 31, 2021
Issuance of Shares
From June 30, 2021 to September 30, 2021
Issuance of Shares
From March 31, 2021 to June 30, 2021
Issuance of Shares
From December 31, 2020 to March 31, 2021
Issuance of Shares
From December 31,2019 to December 31,2020
Issuance of Shares
From March 31, 2020 to June 30, 2020
Issuance of Shares
From December 31, 2019 to March 31, 2020
Issuance of Shares
From December 31, 2018 to December 31, 2019
Issuance of Treasury Shares
Issuance of Shares
From March 31, 2019 to June 30, 2019
Issuance of Treasury Shares
from December 31, 2018 to March 31, 2019
Issuance of shares
from December 31, 2017 to December 31, 2018
Issuance of shares
Issuance of Treasury Shares
from December 31, 2016 to December 31, 2017
Exercise of options by employees and vested RSUs
from December 31, 2015 to December 31, 2016
Ordinary shares issuance
Exercise of options by employees and vested RSUs
from December 31, 2014 to December 31, 2015
Ordinary shares issuance
Exercise of options by employees and vested RSUs
Purchase of treasury shares
from December 31, 2013 to December 31, 2014
Exercise of options and RSUs by employees
Purchase of treasury shares
from December 31,2012 to December 31,2013
Exercise of options and RSUs by employees
Purchase of treasury shares
from December 31, 2011 to December 31, 2012
Exercise of options and RSUs by employees
Treasury shares
from December 31, 2010 to December 31, 2011
Exercise of options and RSUs by employees
Conversion of convertible senior debentures
Treasury shares
from December 31, 2009 to December 31, 2010
Exercise of options and RSUs by employees
Conversion of convertible senior debentures
from December 31, 2008 to December 31, 2009
Conversion of convertible senior debentures
Exercise of options by employees
Stock-based compensation expense
Excess tax benefit on options exercised
from December 31, 2007 to December 31, 2008
Issuance of shares and stock options on acquisitions
Conversion of convertible senior debentures
Exercise of options by employees
Stock-based compensation expense
Excess tax benefit on options exercised
Decrease
from December 31, 2006 to December 31, 2007
Conversion of convertible senior debentures
Exercise of options by employees
Stock-based compensation expense
Excess tax benefit on options exercised
Increase
from December 31, 2005 to December 31, 2006
Issuance of shares and stock option on acquisition of Ivax
Ordinary shares issued in exchange for special shares
Exercise of options by employees
Conversion of convertible senior debentures, net of tax
Treasury shares
from December 31, 2004 to December 31, 2005
Ordinary shares issued in exchange for special shares
Exercise of options by employees
Conversion of Convertible Senior Debentures and related tax effect
Cost of acquisition of Company shares, net of proceeds from sale
from December 31, 2003 to December 31, 2004
Issuance of shares, stock options and warrants on acquisition of Sicor
Ordinary shares issued in exchange for special shares
Exercise of options by employees
Conversion of Convertible Senior Debentures
Cost of acquisition of Company shares, net of proceeds from sale
In June 2004, Teva effected a 2:1 stock split
from December 31, 2002 to December 31, 2003
Exercise of options by employees and related tax effect
Conversion of Convertible Senior Debentures and related tax effect
Cost of acquisition of Company shares, net of proceeds from sale
from December 31, 2001 to December 31, 2002
Exercise of options by employees
Ordinary shares issued in exchange for special shares
Cost of acquisition of Company shares, net of proceeds from sale
At the end of 2002, Teva announced a 2:1 stock split